Biomarkers that reflect tumor cell proliferation, such as p53 or Ki-67 (MIB-1), have been investigated in other studies with controversial results on survival and recurrent outcomes, although some reported Ki-67 as an unfavorable prognostic factor [38,39]. The gene discussed is MKI67; the disease is neoplasm.